wDR 2.2 Mobile Digital Diagnostic X-Ray System

FDA Device Recall #Z-2045-2023 — Class II — May 23, 2023

Recall Summary

Recall Number Z-2045-2023
Classification Class II — Moderate risk
Date Initiated May 23, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm SEDECAL SA
Location Algete, N/A
Product Type Devices
Quantity 1061 units

Product Description

wDR 2.2 Mobile Digital Diagnostic X-Ray System

Reason for Recall

There is a software login in issue that may prevent the user from logging in.

Distribution Pattern

Distribution throughout United States including Puerto Rico and US Virgin Islands OUS distribution to Albania, Argentina, Australia, Austria, Bahrain, Bangladesh, Belgium, Botswana, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Curacao, Czech Republic, Dominican Republic, Egypt, Finland, France, Germany, Hungary, Indonesia, Iran, Iraq, Israel, Italy, Japan, Jordan, Kazakhstan, Kenya, Kosovo, Kuwait, Latvia,Lebanon, Libya, Lithuania, Luxembourg, Malaysia, Malta, Martinique, Mexico, Myanmar, Netherlands, New Zealand, Nigeria, Norway, Pakistan, Panama, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Suriname, Sweden, Switzerland, Tanzania, Thailand, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Ukraine, United Arab Emirates, United Kingdom, Uzbekistan, Vietnam, and Zambia

Lot / Code Information

Model MobileDiagnost wDR: 1) Model Number 712007, Software versions 2.2.0, 2.2.1, 2.2.2, and 2.2.3 2) Model Number 712006, Software versions 2.2.0, 2.2.1, 2.2.2, and 2.2.3 3) Model Number 712004, Software version 2.1 with Windows 10 Upgrade 4) Model Number 712002, Software version 2.1 with Windows 10 Upgrade

Other Recalls from SEDECAL SA

Recall # Classification Product Date
Z-0243-2026 Class II MobileDiagnost wDR 2.2; Model Number REF 9890-0... Jun 10, 2025
Z-0255-2026 Class II Model Number SM-32HF-B-D-C; 32KW 50G, Mobile X-... Jun 10, 2025
Z-0275-2026 Class II Model Number SM-40HF-B-D-C; 40KW CANON READY, M... Jun 10, 2025
Z-0248-2026 Class II Model Number 40KWFXPLUS.004, Mobile X-ray system Jun 10, 2025
Z-0270-2026 Class II Model Number SM-40HF-B-D-C; 40KW 55C/60C, Mobil... Jun 10, 2025

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.